about
The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin developmentThe carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferationEpstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriersIsolation of rare circulating tumour cells in cancer patients by microchip technologyEpithelial cell dissemination and readhesion: analysis of factors contributing to metastasis formation in breast cancerIdentification of EpCAM as the gene for congenital tufting enteropathyCellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell linesThe epithelial cellular adhesion molecule (Ep-CAM) is a ligand for the leukocyte-associated immunoglobulin-like receptor (LAIR)Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevanceThe plastic cellular states of liver cells: Are EpCAM and Lgr5 fit for purpose?Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancerThe evolving role of catumaxomab in gastric cancerEpCAM in carcinogenesis: the good, the bad or the uglyGenetic abolishment of hepatocyte proliferation activates hepatic stem cellsGrainyhead-like 2 regulates neural tube closure and adhesion molecule expression during neural fold fusionFast and selective cell isolation from blood sample by microfiber fabric system with vacuum aspiration.EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell featuresSquishy non-spherical hydrogel microparticles.In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set.Determination of disulfide bond assignments and N-glycosylation sites of the human gastrointestinal carcinoma antigen GA733-2 (CO17-1A, EGP, KS1-4, KSA, and Ep-CAM).Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic markerNovel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes.Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodiesSimultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth.Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).Targeted drug delivery in pancreatic cancerFunctional effects of Toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cellsEpithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cellsSorting mouse jejunal epithelial cells with CD24 yields a population with characteristics of intestinal stem cells.RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule.A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effectCancer therapy with bispecific antibodies: Clinical experience.The novel EpCAM-targeting monoclonal antibody 3-17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines.The architecture and biological function of dual antibody-coated dendrimers: enhanced control of circulating tumor cells and their hetero-adhesion to endothelial cells for metastasis prevention.Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers.The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.Expression pattern of epithelial cell adhesion molecule on normal and malignant colon tissuesA Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCGrefractory and BCG-intolerant patients.Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate-specific membrane antigen aptamers immobilized to a polymeric microfluidic device.mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/β-catenin.
P2860
Q21563339-4D998CFF-5297-4EDB-9515-7888ACAE6D77Q24296763-41426A1D-8376-4CC6-A3DE-0D278E865B87Q24561854-865784D8-0AF2-4B0E-8309-71828954AB60Q24597164-DCAE60E9-506E-4D2F-92F1-668E6E437F41Q24606925-9D40D2D9-36C7-4CE9-B917-AB6458C83663Q24647346-42596BB0-7931-43C8-A578-09DE3EFFBA46Q24650717-C69DF834-79C5-42FF-BF09-7E8A79A1FD7FQ24675606-A9554A34-2447-4788-BB66-9C61AB8019EFQ24806218-D60FDC19-FBF8-4F54-B255-E970B4E6B318Q26769613-99F431FA-5025-4EB8-9F1A-B9134E015EC5Q28235980-9571B36E-4086-4805-8843-7F68C006FE80Q28290511-3A5968CB-F49F-48EC-ACB9-96222488BFC7Q28293163-19000AE3-A076-4CE5-AE95-F1891F5BC07FQ28481211-92F21588-ADD5-4B92-B3FF-3FBFA5F74FA5Q28511638-50417CEC-D426-45BC-979B-F900F5184C00Q30368315-65121A43-AEC4-4CFF-85A6-8EC60E09BB09Q30493364-4E47A1C5-8708-44BE-ABD7-47AE5ECB1C09Q30502485-91B36A41-9529-4F8E-BC2E-E36769A372BEQ30704402-FD341422-9BD5-4D53-A2D4-7ECE7F7219C1Q30963142-20C31DE5-B20E-449E-A8C3-342241D0339AQ33247794-3994633A-3A92-436E-818B-926204CC45DCQ33511673-3DE85055-9688-4E89-842E-B5978A8A806FQ33567376-1BA62D3E-DBDE-4566-85FE-C785A85CA8A0Q33588273-1C6B462F-C65A-4912-B4CD-E60FBB4A9B54Q33590557-7D298E3E-3C0C-4498-88D1-4A214A9AC3A9Q33625651-28FD14FE-22EB-44A4-99ED-991F348DF07EQ33699965-4CC3FE07-6A02-432F-B0B5-055D3B7A6A8AQ33726440-2054F678-FE80-4D4B-B1DC-A171A34CF082Q33779894-B7017346-DEDC-4AF6-9FF1-FC34B8C5DD4AQ33807710-6CAD772B-3AB0-4728-A1CC-97C1CB54EF0BQ34008026-F341FCA5-BEF0-4E5A-8E79-0B669BABB76BQ34118856-B1C81264-761E-45A8-AC57-1FD798142AFDQ34223880-AAB3EBC9-6371-4826-B464-54E2EC87559DQ34284428-1CB4F680-4077-4AD6-B512-15054403C0D4Q34348691-BECCE296-70A9-4927-8627-D532F1D1358EQ34365135-98632FE6-76A1-49B3-8EDF-2D7AE3DD5862Q34382238-0100A1BE-5D64-4A64-9148-7318A878C5D5Q34389519-92468C97-0809-4B99-B382-A16101C244B9Q34440166-9151FE39-1AA1-4B33-AC2B-53BAB23C4A38Q34499625-B74815C6-0ACE-4725-BA43-C2F0F1D18ECE
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The biology of the 17-1A antigen (Ep-CAM)
@ast
The biology of the 17-1A antigen (Ep-CAM)
@en
The biology of the 17-1A antigen (Ep-CAM)
@nl
type
label
The biology of the 17-1A antigen (Ep-CAM)
@ast
The biology of the 17-1A antigen (Ep-CAM)
@en
The biology of the 17-1A antigen (Ep-CAM)
@nl
prefLabel
The biology of the 17-1A antigen (Ep-CAM)
@ast
The biology of the 17-1A antigen (Ep-CAM)
@en
The biology of the 17-1A antigen (Ep-CAM)
@nl
P2093
P356
P1476
The biology of the 17-1A antigen (Ep-CAM)
@en
P2093
C J de Boer
M J Winter
S V Litvinov
P2888
P304
P356
10.1007/S001099900038
P407
P577
1999-10-01T00:00:00Z
P6179
1026939993